Both SCC and ADC low phosphorylation MYPT1 groups showed significantly longer survival outcomes (25 and 45 months, respectively), compared to high phosphorylation countergroups (21 and 39 months), suggesting that total MYPT1 levels may not be as prognostically relevant as its phosphorylation status. The gene discussed is PPP1R12A; the disease is AIDS dementia complex.